Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
e-6201 (2 trials)
sotorasib (LUMAKRAS) (1 trial)
vic-1911 (1 trial)
Melanoma (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 1)
Trials (3 total)
Trial APIs (3 total)